National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportMadan Jagasia, Mary E.D. Flowers, Howard M. Shulman et al.|Biology of Blood and Marrow Transplantation|2014Cited by 5.4k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Per Ljungman et al.|New England Journal of Medicine|2017Cited by 1.2k
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Sophie Alain, Barbara D. Alexander et al.|Clinical Infectious Diseases|2021Cited by 299
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumoniaC. Avendaño, Rafael F. Duarte, António Ramos et al.|Journal of Clinical Investigation|2021Cited by 110